A recent study published in Nature Communications found a strong association between higher consumption of food preservatives and an increased risk of type 2 diabetes. The research, which analyzed data from over 100,000 adults, suggests that even small amounts of preservative additives can have significant health consequences.
Researchers developed an ultrasound probe capable of imaging an entire organ in 4D, allowing for better understanding of the circulatory system and diagnosis of blood circulation-related diseases. The technology enables visualization of microcirculation and assessment of the entire circulatory system with unprecedented image resolution.
A clinical trial found that a subretinal implant partially restored sight in over 80% of participants with age-related macular degeneration (AMD), enabling them to read letters, numbers, and words. The device demonstrated significant benefits, including improved visual acuity and letter recognition.
Researchers have established a causal link between mitochondrial dysfunction and cognitive symptoms associated with neurodegenerative diseases. By stimulating mitochondrial activity, they observed an improvement in memory deficit symptoms in animal models. The study opens the door to considering mitochondria as a new therapeutic target.
A new study analyzed health data of over 100,000 adults and found that two food additive mixtures were associated with a higher incidence of type 2 diabetes. The mixtures contained emulsifiers, sweeteners, and colourings commonly found in ultra-processed foods.
A new study developed an AI-powered algorithm that accurately predicted sudden cardiac death risk in over 70% of cases. The algorithm analyzed data from 240,000 ambulatory electrocardiograms and identified patients at risk of severe arrhythmias within two weeks.
A new study has identified two distinct subtypes of metabolic dysfunction-associated steatotic liver disease (MASH) with similar histological features but different clinical outcomes. The research empowers clinicians to adopt subtype-specific treatments leveraging simple clinical markers, offering a clear path to improve patient outcomes.
The CSF-2023 survey, conducted across France and its overseas territories, explores diverse forms of sexuality and sexual health practices. The research provides key indicators to evaluate the country's national sexual health strategy, building on previous surveys' methodologies.
Researchers found an association between consuming foods with lower nutritional quality and a higher risk of cardiovascular diseases, particularly myocardial infarction and stroke. The study used the latest version of the Nutri-Score algorithm and included over 345,000 participants from seven European countries.
A large-scale randomized clinical trial confirms the safety of three Ebola vaccine regimens, inducing an immune response that persists for up to 12 months. The study suggests that vaccines can be a crucial tool in fighting the spread of the disease in sub-Saharan African countries.
Scientists have identified a potential therapy to reduce the side effects of cisplatin chemotherapy, which can cause kidney toxicity and neuropathic pain. Istradefylline, an approved Parkinson's disease drug, has been found to mitigate these harmful effects while preserving cisplatin's anti-tumor properties.
Researchers found that administering nitric oxide to preterm mice after birth can reverse symptoms of congenital hypogonadotropic hypogonadism, including sensory and cognitive disorders. A clinical trial is now underway to test this treatment in human preterm infants.
Researchers developed a therapy using GnRH pulsatile injection to restore cognitive and olfactory functions in trisomic mice. In a pilot clinical trial, the treatment improved cognitive performance in 6 out of 7 patients with Down syndrome, including better reasoning, attention, and episodic memory.
Scientists have developed a DNA nano-robot that can apply forces with unprecedented accuracy, enabling closer study of mechanical forces at microscopic levels. The robot is designed to target specific mechanoreceptors, allowing researchers to activate them and study key signaling pathways involved in biological processes.
Scientists have developed a new class of antidiabetic drugs called Adipeutics that specifically target adipocytes to restore glucose uptake. This therapy has shown promising results in animal models and holds potential for addressing not only type 2 diabetes but also related medical conditions.
Scientists locate highly effective memory B cells in the lungs, which can boost the efficacy of vaccines used to protect against viral respiratory diseases. The discovery suggests a promising avenue for increasing vaccine effectiveness.
Researchers have discovered that changes in dopamine D2 receptors in specific cerebellar cells can alter sociability and preference for social novelty. This finding has implications for understanding psychiatric disorders such as autism spectrum disorder, bipolar mood disorder, and schizophrenia.
A new mathematical model predicts the efficacy of phage therapy against pathogenic bacteria, highlighting key parameters for effective treatment. The model incorporates data on bacteriophage interactions with the immune system and suggests optimizing administration routes to improve outcomes.
Researchers have identified 75 regions of the genome associated with Alzheimer's disease, including 42 novel regions. The study confirms the importance of pathological processes such as amyloid peptide production and tau protein function in the disease. A genetic risk score has also been devised to better evaluate patient risk.
A recent study found that using mechanical tools can improve understanding of complex sentences and vice versa. Researchers discovered that motor training with tools activates the same brain region as syntax exercises, suggesting that these skills rely on shared neurological resources.
A novel COVID-19 vaccine candidate demonstrates high efficacy in preclinical models by stimulating the immune system and inducing a robust neutralizing antibody response. The vaccine protects against reinfection and provides better protection than natural immunity, making it a potential supplement to existing vaccines.
Scientists discovered impaired leptin transport to the brain via LepR receptors leads to pre-diabetic state and exhausted insulin secretion. Reintroducing leptin restores pancreatic function-promoting action, suggesting a crucial brain role in type 2 diabetes management.
Researchers have discovered the crucial role of astrocytes in closing the period of brain plasticity following birth. Transplanting immature astrocytes into adult mice has been shown to reintroduce brain plasticity, suggesting a potential therapeutic strategy for rehabilitation after brain lesions or neurodevelopmental disorders.
A study found that type 1 interferon deficiency is a biomarker for patients at risk of severe COVID-19. Low levels of type 1 interferon in plasma precede clinical worsening and are characteristic of each stage of the disease, suggesting it could identify a high-risk population.
Research reveals that cannabis exposure leads to dysfunction of glucose metabolism in astrocytes, compromising neuronal functioning and resulting in reduced social interactions. The study sheds light on the link between cannabis use and sociability, highlighting potential therapeutic solutions.
African countries with strong preparedness and detection capabilities are better equipped to handle a potential outbreak, while those with lower scores face significant risks of nondetection and local spread.
A brain imaging study found that PTSD patients have a deficiency in mechanisms that suppress and regulate memory activity, particularly in the hippocampus. The study suggests that these dysfunctioning systems contribute to the persistence of intrusive memories.
Scientists at Inserm have cultivated human cells in the lab to produce extracellular matrix deposits high in collagen, which can be woven into yarn to replace damaged blood vessels. This biologically derived material is expected to be well-accepted by the body and could lead to clinical trials.
A vaccine clinical trial for pregnant women with malaria has shown promising results, demonstrating safety and an appropriate immune response. The PRIMVAC vaccine was found to be well-tolerated and induced antibodies capable of recognizing the Plasmodium falciparum parasite.
Researchers at INSERM have revealed that whole functioning extracellular mitochondria are present in the bloodstream, contradicting previous assumptions. The discovery has significant implications for our understanding of physiology and could lead to improvements in diagnosis and treatment of diseases.
A new study found that reinforcing the meningeal lymphatic network increases tumor antigen traffic from the meninges to lymph nodes, triggering activation of immune cells against the tumor. This approach combines with existing immunotherapy for effective glioblastoma eradication.
Researchers have found that B cells play a crucial role in the response to immunotherapy for certain types of cancer, including soft tissue sarcomas. These cells, which were previously thought to be passive bystanders, are now seen as key players in the anti-tumor immune response.
The Partnership for Research on Ebola Vaccination (PREVAC) has received additional funding to evaluate three Ebola vaccine regimens for long-term safety and durability. The PREVAC-UP project will assess these factors over 5 years after vaccination, as well as the impact of co-infections like malaria and helminths on immune responses.
Researchers developed a vaccine that targets flagellin in the gut microbiota to reduce inflammation. The vaccine showed protection against intestinal inflammation and metabolic disorders such as diabetes and obesity.
Research finds high-intensity sporting physical activity improves neural baroreflex, while physical activity at work is associated with abnormal neural baroreflex and greater arterial stiffness. Chronic, strenuous activity at work may pose a risk to cardiovascular health.
Acute myeloid leukemia (AML)-M7 is the most aggressive subtype of leukemia affecting children, with a poor prognosis. Research reveals that this disease develops specifically in young patients due to differences in fetal cells, and that targeting surrounding proteins may improve treatments.
A recent study by Inserm US14 found that more than 300 million people worldwide are currently living with a rare disease, which represents around 4% of the world's population. The study analyzed data from the Orphanet database and estimated that this number could be higher due to many cases being unrecorded in healthcare systems.
Researchers have identified a key mechanism underlying atopic dermatitis, a chronic inflammatory skin disease affecting 20% of children and 5% of adults. The study reveals that mast cells and sensory neurons interact in 'sensory neuroimmune units' to detect allergens, triggering inflammation.
A study shows that intensive physical training can harm brain capacity, particularly cognitive control. Excessive physical activity is linked to reduced activity of the lateral prefrontal cortex, leading to impulsive decision-making and burnout syndrome.
A recent study has identified FHL1 protein as a crucial cellular factor for the replication and pathogenesis of chikungunya virus. The researchers found that FHL1 interacts with viral protein nsP3 to facilitate viral infection, making it a promising target for antiviral development.
A study found that a single dose of yellow fever vaccine may not offer lasting protection to all children, with levels of protective antibodies decreasing substantially over time. The research suggests that booster shots may be necessary for young children, and maintaining immunity is crucial for preventing epidemics.
Research found that interferon production alters placental development, potentially causing serious complications. Interferon-induced transmembrane proteins block syncytin fusion activity, preventing viral entry but also hindering fetal growth.
Researchers have identified a new pathological mechanism responsible for 10-20% of unexplained anaphylactic cases involving IgG antibodies that activate neutrophils, releasing harmful vasodilating mediators. This discovery may help improve diagnosis and treatment for patients with anaphylactic shock.
Researchers at Inserm and Université de Rennes 1 have created new antibiotics effective against Gram-positive and negative multi-resistant bacteria. The compounds, known as peptidomimetics, also appear to prevent the development of resistance when used in mice models.
Researchers observe DNA transmission between resistant and sensitive Escherichia coli bacteria, discovering a generalist efflux pump facilitating minimal protein synthesis activity. This study opens new avenues for understanding bacterial resistance mechanisms and potential therapeutic applications.
A study by Inserm researchers found that cannabinoid type 1 (CB1) receptors control motivation for exercise, but not chocolatey food. The findings suggest that CB1 receptors on GABAergic neurons are essential for physical activity motivation.
Researchers tested rats on GM maize MON 810 and NK603 for 6 months, using high-throughput biology techniques. No significant biological markers were found, and anatomic pathology examination revealed no alteration of organs. The study does not detect any harmful effects of the GMOs on rat health or metabolism.
Researchers have discovered a new therapeutic avenue for treating type 2 diabetes by targeting the interaction between hormone-sensitive lipase (HSL) and a transcription factor responsible for fatty acid synthesis. Decreasing HSL expression leads to improved insulin sensitivity, which may help prevent or manage the disease.
The European Perinatal Health Report shows that stillbirth and neonatal mortality rates decreased in Europe in 2015 compared to 2010. However, the rate of decrease varied widely between countries, with some experiencing significant declines while others saw little change.
Researchers found a genetic variation associated with thymic output in humans, which can affect immune responses. This discovery may help explain differences in immune responses between healthy individuals and has implications for precision medicine and vaccine development.